Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Jun;80(6):e14-e18.
doi: 10.1016/j.jinf.2020.03.005. Epub 2020 Mar 27.

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Affiliations
Comparative Study

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Kai Liu et al. J Infect. 2020 Jun.

Abstract

Background: Due to the general susceptibility of new coronaviruses, the clinical characteristics and outcomes of elderly and young patients may be different.

Objective: To analyze the clinical characteristics of elderly patients with 2019 new-type coronavirus pneumonia (COVID-19).

Methods: This is a retrospective study of patients with new coronavirus pneumonia (COVID-19) who were hospitalized in Hainan Provincial People's Hospital from January 15, 2020 to February 18, 2020. Compare the clinical characteristics of elderly with Young and Middle-aged patients.

Results: A total of 56 patients were enrolled 18 elderly patients (32.14%), and 38 young and middle-aged patients (67.86%). The most common symptoms in both groups were fever, followed by cough and sputum. Four patients in the elderly group received negative pressure ICU for mechanical ventilation, and five patients in the young and middle-aged group. One patient died in the elderly group (5.56%), and two patients died in the young and middle-aged group (5.26%). The PSI score of the elderly group was higher than that of the young and middle-aged group (P < 0.001). The proportion of patients with PSI grades IV and V was significantly higher in the elderly group than in the young and middle-aged group (P < 0.05). The proportion of multiple lobe involvement in the elderly group was higher than that in the young and middle-aged group (P < 0.001), and there was no difference in single lobe lesions between the two groups. The proportion of lymphocytes in the elderly group was significantly lower than that in the young and middle-aged group (P < 0.001), and the C-reactive protein was significantly higher in the young group (P < 0.001). The Lopinavir and Ritonavir Tablets, Chinese medicine, oxygen therapy, and mechanical ventilation were statistically different in the elderly group and the young and middle-aged group, and the P values were all <0.05.

Interpretation: The mortality of elderly patients with COVID-19 is higher than that of young and middle-aged patients, and the proportion of patients with PSI grade IV and V is significantly higher than that of young and middle-aged patients. Elderly patients with COVID-19 are more likely to progress to severe disease.

Keywords: COVID-19; Clinical feature; Elderly patients; Young and middle-aged patients.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None declared.

Comment in

Similar articles

Cited by

References

    1. Li J.-.Y., You Z. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect. 2020 In press, journal pre-proof Available online 20 February 2020. - PMC - PubMed
    1. Guan W.J., Ni Z.Y., Zhong N.S., et al. Clinical characteristics of 2019 novel coronavirus infection in China. Med Rxiv, 2020, [Epub ahead of print]. 10.1101/2020.02.06.20020974. - DOI
    1. Yang Y., Lu Q.B., Liu M.J., et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. Med Rxiv, 2020, [Epub ahead of print]. DOI: 10.1101/2020.02.10.20021675 - DOI
    1. Liu Y., Gayle A.A., Wilder-Smith A. The reproductive number of COVID−19 is higher compared to SARS coronavirus. J Travel Med. 2020 doi: 10.1093/jtm/taaa021. [Epub ahead of print] - DOI - PMC - PubMed
    1. Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERSepidemic. Asian Pac J Allergy Immunol. 2020 doi: 10.12932/AP-200220-0772. - DOI - PubMed

Publication types

MeSH terms